You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 40 Novel biomarker assays for detecting labyrinthin-positive adenocarcinomas for a phase I/II trial of peptide vaccine LabVax 3(22)-23 alone or in combination with pembrolizumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
40 Novel biomarker assays for detecting labyrinthin-positive adenocarcinomas for a phase I/II trial of peptide vaccine LabVax 3(22)-23 alone or in combination with pembrolizumab

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023194018
Dec 202369015
Jan 20241801
Feb 20245808
Mar 20244003
Apr 20244806
May 20246503
Jun 20242202
Jul 20242605
Aug 20243705
Sep 20244004
Oct 20241604
Nov 202420014
Dec 20247804
Jan 20256809
Feb 2025806
Mar 2025007
Apr 2025002
May 2025007
Jun 2025003
Total8070126